Expression of mage-A4 and mage-C1 tumor-associated antigen in benign and malignant thyroid diseases

Head and Neck

Volumn 33, Issue 10, 2011, Pages 1426-1432

  Melo, Daniel Hardy ^a   Mamede, Rui Celso Martins ^a   Neder, Luciano ^a   Saggioro, Fabiano Pinto ^a   Figueiredo, David Livingstone Alves ^a   Araújo Da Silva Jr , Wilson ^a   Jungbluth, Achim A ^b   Zago, Marco Antônio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

biological tumor markers; immunohistochemistry; MAGE A4; MAGE C1; thyroid diseases

Indexed keywords

MELANOMA ANTIGEN 4; MELANOMA ANTIGEN C1 PROTEIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADENOMA; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLICULAR CARCINOMA; GOITER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CANCER; THYROID DISEASE; THYROID PAPILLARY CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; ADOLESCENT; ADULT; ANTIGENS, NEOPLASM; CARCINOMA, PAPILLARY; FEMALE; GOITER; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; THYROID NEOPLASMS;

EID: 80052965876     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21616     Document Type: Article

References (21)

1. Hirokawa M, Carney JA, Goellner JR, et al. Observer variation of encapsulated follicular lesions of the thyroid gland. Am J Surg Pathol 2002; 26: 1508-1514.
2. LiVolsi VA, Merino MJ,. Worrisome histologic alterations following fine needle aspiration of the thyroid. Pathol Annu 1994; 29: 99-120.
3. Suster S,. Thyroid tumors with a follicular growth pattern: problems in differential diagnosis. Arch Pathol Lab Med 2006; 130: 984-988.
4. Cerilli LA, Mills SE, Rumpel CA, Dudley TH, Moskaluk CA,. Interpretation of RET immunostaining in follicular lesions of the thyroid. Am J Clin Pathol 2002; 118: 186-193.
5. Weber F, Shen L, Aldred MA, et al. Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination. J Clin Endocrinol Metab 2005; 90: 2512-2521.
6. Figueiredo DL, Mamede RC, Proto-Siqueira R, Neder L, Silva WA Jr, Zago MA,. Expression of cancer testis antigens in head and neck squamous cell carcinomas. Head Neck 2006; 28: 614-619.
7. Ruschenburg I, Kubitz A, Schlott T, Korabiowska M, Droese M,. MAGE-1, GAGE-1/-2 gene expression in FNAB of classic variant of papillary thyroid carcinoma and papillary hyperplasia in nodular goiter. Int J Mol Med 1999; 4: 445-448.
8. Maio M, Coral S, Sigalotti L, et al. Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1. J Clin Endocrinol Metab 2003; 88: 748-754.
9. Milkovic M, Sarcevic B, Glavan E,. Expression of MAGE tumor-associated antigen in thyroid carcinomas. Endocr Pathol 2006; 17: 45-52.
10. Cheng S, Liu W, Mercado M, Ezzat S, Asa SL,. Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer. Endocr Relat Cancer 2009; 16: 455-466.
11. Iwamoto O, Nagao Y, Shichijo S, Eura M, Kameyama T, Itoh K,. Detection of MAGE-4 protein in sera of patients with head-and-neck squamous-cell carcinoma. Int J Cancer 1997; 70: 287-290.
12. Prasad ML, Jungbluth AA, Patel SG, Iversen K, Hoshaw-Woodard S, Busam KJ,. Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck. Head Neck 2004; 26: 1053-1057.
13. Ries J, Schultze-Mosgau S, Neukam F, Diebel E, Wiltfang J,. Investigation of the expression of melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous cell carcinomas to determine potential targets for gene-based cancer immunotherapy. Int J Oncol 2005; 26: 817-824.
14. Jungbluth AA, Chen YT, Busam KJ, et al. CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues. Int J Cancer 2002; 99: 839-845.
15. Sharma P, Shen Y, Wen S, et al. Cancer-testis antigens: expression and correlation with survival in human urothelial carcinoma. Clin Cancer Res 2006; 12: 5442-5447.
16. Tajima K, Obata Y, Tamaki H, et al. Expression of cancer/testis (CT) antigens in lung cancer. Lung Cancer 2003; 42: 23-33.
17. Kobayashi T, Lonchay C, Colau D, Demotte N, Boon T, van der Bruggen P,. New MAGE-4 antigenic peptide recognized by cytolytic T lymphocytes on HLA-A1 tumor cells. Tissue Antigens 2003; 62: 426-432.
18. Rigopoulou D, Martinez-Laso J, Martinez-Tello F, et al. Both class I and class II HLA antigens are thyroid cancer susceptibility factors. Tissue Antigens 1994; 43: 281-285.
19. Old LJ,. Cancer vaccines: an overview. Cancer Immun 2008; 8 (Suppl 1): 1-4.
20. Old LJ,. Cancer vaccine collaborative 2002: opening address. Cancer Immun 2003; 3 (Suppl 1): 1-8.
21. Shaha A, Shah JP, Loree T,. Patterns of failure in differentiated carcinoma of the thyroid based on risk groups. Head Neck 1998; 20: 26-30.